Davida F Kruger

Summary

Affiliation: Henry Ford Hospital
Country: USA

Publications

  1. ncbi request reprint A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes
    Fred Whitehouse
    Henry Ford Hospital, Detroit, Michigan, USA
    Diabetes Care 25:724-30. 2002
  2. ncbi request reprint New landscape of type 2 diabetes management
    Davida F Kruger
    Division of Endocrinology, Diabetes, and Bone Disorders, Henry Ford Medical Center, Detroit, Michigan, USA
    J Am Acad Nurse Pract 19:5-10. 2007
  3. doi request reprint Managing diabetes with integrated teams: maximizing your efforts with limited time
    Davida F Kruger
    Henry Ford Health System, Division of Endocrinology, Diabetes, Bone, and Mineral Disorders, Detroit, MI, USA
    Postgrad Med 124:64-76. 2012
  4. doi request reprint Managing diabetes from first diagnosis: choosing well-tolerated therapies with durability
    Davida F Kruger
    Henry Ford Health System, Divsion of Endocrinology, Diabetes, Bone and Mineral Disease, New Center One, 3031 West Grand Blvd, Suite 800, Detroit, MI 48202 3031, USA
    Diabetes Educ 38:4S-11S; quiz 12S. 2012
  5. doi request reprint Intensifying insulin treatment: options, practical issues, and the role of the nurse practitioner
    Davida F Kruger
    Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health System, Detroit, Michigan 48202, USA
    J Am Acad Nurse Pract 24:260-9. 2012
  6. ncbi request reprint Through the looking glass: current and future perspectives on the role of hormonal interplay in glucose homeostasis
    Davida F Kruger
    Henry Ford Health System, Division of Endocrinology and Metabolism, 3031 West Grand Boulevard, Suite 800, Detroit, MI 48202, USA
    Diabetes Educ 33:32S-46S; quiz 47S-48S. 2007
  7. doi request reprint Exploring the pharmacotherapeutic options for treating type 2 diabetes
    Davida F Kruger
    Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Medical Center, Detroit, MI 48202, USA
    Diabetes Educ 34:60S-65S. 2008
  8. ncbi request reprint New insights into glucose regulation
    Davida F Kruger
    Henry Ford Medical Center, New Center One, 3031 W Grand Blvd, Suite 800, Detroit, MI 48202, USA
    Diabetes Educ 32:221-8. 2006
  9. ncbi request reprint Pramlintide for the treatment of insulin-requiring diabetes mellitus: rationale and review of clinical data
    Davida F Kruger
    Endocrinology and Metabolism, Henry Ford Health System, 2799 West Grand Boulevard, K 16, Detroit, MI 48202, USA
    Drugs 64:1419-32. 2004
  10. doi request reprint Understanding GLP-1 analogs and enhancing patients success
    Davida F Kruger
    Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health System, Detroit, Michigan 48202, USA
    Diabetes Educ 36:44S-72S; quiz 73S-74S. 2010

Collaborators

Detail Information

Publications19

  1. ncbi request reprint A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes
    Fred Whitehouse
    Henry Ford Hospital, Detroit, Michigan, USA
    Diabetes Care 25:724-30. 2002
    ..To assess the effect of mealtime amylin replacement with pramlintide on long-term glycemic and weight control in patients with type 1 diabetes...
  2. ncbi request reprint New landscape of type 2 diabetes management
    Davida F Kruger
    Division of Endocrinology, Diabetes, and Bone Disorders, Henry Ford Medical Center, Detroit, Michigan, USA
    J Am Acad Nurse Pract 19:5-10. 2007
  3. doi request reprint Managing diabetes with integrated teams: maximizing your efforts with limited time
    Davida F Kruger
    Henry Ford Health System, Division of Endocrinology, Diabetes, Bone, and Mineral Disorders, Detroit, MI, USA
    Postgrad Med 124:64-76. 2012
    ....
  4. doi request reprint Managing diabetes from first diagnosis: choosing well-tolerated therapies with durability
    Davida F Kruger
    Henry Ford Health System, Divsion of Endocrinology, Diabetes, Bone and Mineral Disease, New Center One, 3031 West Grand Blvd, Suite 800, Detroit, MI 48202 3031, USA
    Diabetes Educ 38:4S-11S; quiz 12S. 2012
    ..A case study is used to describe the process of choosing well-tolerated therapies at first diagnosis...
  5. doi request reprint Intensifying insulin treatment: options, practical issues, and the role of the nurse practitioner
    Davida F Kruger
    Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health System, Detroit, Michigan 48202, USA
    J Am Acad Nurse Pract 24:260-9. 2012
    ..This article summarizes practical considerations in the management of T2D at this stage...
  6. ncbi request reprint Through the looking glass: current and future perspectives on the role of hormonal interplay in glucose homeostasis
    Davida F Kruger
    Henry Ford Health System, Division of Endocrinology and Metabolism, 3031 West Grand Boulevard, Suite 800, Detroit, MI 48202, USA
    Diabetes Educ 33:32S-46S; quiz 47S-48S. 2007
  7. doi request reprint Exploring the pharmacotherapeutic options for treating type 2 diabetes
    Davida F Kruger
    Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Medical Center, Detroit, MI 48202, USA
    Diabetes Educ 34:60S-65S. 2008
    ..Exenatide mimics the actions of the hormone GLP-1 that occurs naturally in the gastrointestinal tract and has emerged as an efficacious therapy adjunct to 1 or more oral hypoglycemic agent(s)...
  8. ncbi request reprint New insights into glucose regulation
    Davida F Kruger
    Henry Ford Medical Center, New Center One, 3031 W Grand Blvd, Suite 800, Detroit, MI 48202, USA
    Diabetes Educ 32:221-8. 2006
    ..The discoveries of amylin and GLP-1 have furthered our understanding of the abnormalities involved in diabetes, enabling the development of additional therapeutic options...
  9. ncbi request reprint Pramlintide for the treatment of insulin-requiring diabetes mellitus: rationale and review of clinical data
    Davida F Kruger
    Endocrinology and Metabolism, Henry Ford Health System, 2799 West Grand Boulevard, K 16, Detroit, MI 48202, USA
    Drugs 64:1419-32. 2004
    ..5-1.4kg) and no significant increase in severe hypoglycaemia. Pramlintide treatment as a potential adjunct to insulin therapy is in late-stage development for patients with type 1 diabetes and insulin-using patients with type 2 diabetes...
  10. doi request reprint Understanding GLP-1 analogs and enhancing patients success
    Davida F Kruger
    Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health System, Detroit, Michigan 48202, USA
    Diabetes Educ 36:44S-72S; quiz 73S-74S. 2010
    ..A clear understanding of the evidence base for these drugs will translate into improved education of patients regarding their options to improve glycemic control and, ultimately, to better patient care...
  11. doi request reprint Utilizing current diagnostic criteria and treatment algorithms for managing type 2 diabetes mellitus
    Davida F Kruger
    Henry Ford Medical Group, Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Detroit, MI 48202, USA
    Postgrad Med 123:54-62. 2011
    ..This review highlights recent changes in the guidelines and uses a case-based format to illustrate how the current guidelines may be tailored to fit individual patient characteristics and circumstances...
  12. ncbi request reprint Tying it all together: matching insulin regimens to individual patient needs
    Davida F Kruger
    Henry Ford Health System, Detroit, Michigan, USA
    Diabetes Educ 33:91S-95S. 2007
  13. ncbi request reprint The other "insulin resistance": overcoming barriers to insulin use and encouraging diabetes self-management
    Davida F Kruger
    Henry Ford Health System, Detroit, Michigan, USA
    Diabetes Educ 33:80S-81S. 2007
  14. ncbi request reprint Basal-prandial insulin: when is the right time to initiate treatment?
    Davida F Kruger
    Henry Ford Health System, Detroit, MI, USA
    Nurse Pract 32:24-9; quiz 29-30. 2007
  15. ncbi request reprint Effect of modem transmission of blood glucose data on telephone consultation time, clinic work flow, and patient satisfaction for patients with gestational diabetes mellitus
    Davida F Kruger
    Henry Ford Health System, Detroit, Michigan, USA
    J Am Acad Nurse Pract 15:371-5. 2003
    ..Participant and health care provider satisfaction with the technique was also assessed...
  16. doi request reprint Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment
    Stephen W Ponder
    Children s Diabetes and Endocrine Center of South Texas, Corpus Christi, Texas, USA
    Diabetes Educ 34:327-33. 2008
    ..The purpose of this review study was to determine and categorize common causes of intermittent hyperglycemia and suggest potential measures to prevent and treat the identified causes...
  17. ncbi request reprint Self-management support for insulin therapy in type 2 diabetes
    Martha M Funnell
    Michigan Diabetes Research and Training Center, 1331 East Ann Street, Room 5111, Box 0580, Ann Arbor, MI 48109 0580, USA
    Diabetes Educ 30:274-80. 2004
    ..The purpose of this article is to describe the self-management support that can be provided by diabetes educators for type 2 diabetes patients who are transitioning from therapy with oral hypoglycemic agents to insulin...
  18. ncbi request reprint Type 2 diabetes: treat to target
    Martha M Funnell
    Michigan Diabetes Research and Training Center, Ann Arbor, Mich, USA
    Nurse Pract 29:11-5, 19-23; quiz 23-5. 2004
    ....
  19. ncbi request reprint Translation of the diabetes nutrition recommendations for health care institutions
    Rebecca G Schafer
    Diabetes Care 26:S70-2. 2003